Growth Attenuation in Children with Profound Disabilities

Abstract

Dr Vizcarrondo has disclosed no financial relationship relevant to this commentary. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device. Source: Wilfond B, et al. Navigating growth attenuation in children with profound disabilities. Hastings Center Report. 2010; 40( 6): 27– 40[OpenUrl][1][PubMed][2] In 2006, Ashley, a 6-year-old child with severe developmental disabilities, received treatment at Seattle Children’s Hospital (SCH) with high-dose estrogen and surgical removal of the child’s uterus and breast buds, in order to attenuate her growth to facilitate parental care-giving and to improve her future quality of life. Subsequently, a 20-member working group comprised of ethicists, legal experts, and community representatives was assembled at SCH to discuss ethical and legal aspects of growth attenuation in children like Ashley. In this report the … [1]: {openurl}?query=rft.jtitle%253DHastings%2BCenter%2BReport%26rft.stitle%253DHastings%2BCenter%2BReport%26rft.issn%253D0093-0334%26rft.aulast%253DWilfond%26rft.auinit1%253DB.%2BS.%26rft.volume%253D40%26rft.issue%253D6%26rft.spage%253D27%26rft.epage%253D40%26rft.atitle%253DNavigating%2Bgrowth%2Battenuation%2Bin%2Bchildren%2Bwith%2Bprofound%2Bdisabilities.%2BChildren%2527s%2Binterests%252C%2Bfamily%2Bdecision-making%252C%2Band%2Bcommunity%2Bconcerns.%26rft_id%253Dinfo%253Apmid%252F21155109%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=21155109&link_type=MED&atom=%2Faapgrand%2F25%2F3%2F36.atom